289 related articles for article (PubMed ID: 27043555)
1. Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature.
Gyoba J; Shan S; Roa W; Bédard EL
Int J Mol Sci; 2016 Apr; 17(4):494. PubMed ID: 27043555
[TBL] [Abstract][Full Text] [Related]
2. microRNA and Lung Cancer.
Del Vescovo V; Denti MA
Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer detection by screening - presenting circulating miRNAs as a promising next generation biomarker breakthrough.
Ramshankar V; Krishnamurthy A
Asian Pac J Cancer Prev; 2013; 14(4):2167-72. PubMed ID: 23725107
[TBL] [Abstract][Full Text] [Related]
4. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
5. Serum and blood based biomarkers for lung cancer screening: a systematic review.
Chu GCW; Lazare K; Sullivan F
BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
[TBL] [Abstract][Full Text] [Related]
6. An update on sputum MicroRNAs in lung cancer diagnosis.
Sheervalilou R; Ansarin K; Fekri Aval S; Shirvaliloo S; Pilehvar-Soltanahmadi Y; Mohammadian M; Zarghami N
Diagn Cytopathol; 2016 May; 44(5):442-9. PubMed ID: 26865409
[TBL] [Abstract][Full Text] [Related]
7. Lung Cancer Biomarkers.
I H; Cho JY
Adv Clin Chem; 2015; 72():107-70. PubMed ID: 26471082
[TBL] [Abstract][Full Text] [Related]
8. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
[TBL] [Abstract][Full Text] [Related]
9. Test performance of sputum microRNAs for lung cancer: a meta-analysis.
Liao QB; Guo JQ; Zheng XY; Zhou ZF; Li H; Lai XY; Ye JF
Genet Test Mol Biomarkers; 2014 Aug; 18(8):562-7. PubMed ID: 24892736
[TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
Boeri M; Pastorino U; Sozzi G
Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364
[TBL] [Abstract][Full Text] [Related]
11. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
12. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
[TBL] [Abstract][Full Text] [Related]
13. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
[TBL] [Abstract][Full Text] [Related]
14. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
15. Small non-coding RNA biomarkers in sputum for lung cancer diagnosis.
Su Y; Guarnera MA; Fang H; Jiang F
Mol Cancer; 2016 May; 15(1):36. PubMed ID: 27176474
[TBL] [Abstract][Full Text] [Related]
16. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer.
Liu C; Xiang X; Han S; Lim HY; Li L; Zhang X; Ma Z; Yang L; Guo S; Soo R; Ren B; Wang L; Goh BC
Cancer Lett; 2022 Jan; 524():91-102. PubMed ID: 34656690
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
18. Blood-based Biomarkers for Early Diagnosis of Lung Cancer: A Review Article.
Maharjan N; Thapa N; Tu J
JNMA J Nepal Med Assoc; 2020 Jul; 58(227):519-524. PubMed ID: 32827019
[TBL] [Abstract][Full Text] [Related]
19. Screening for lung cancer: Who should be screened?
Jett J
Arch Pathol Lab Med; 2012 Dec; 136(12):1511-4. PubMed ID: 23194043
[TBL] [Abstract][Full Text] [Related]
20. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
